Suchergebnisse - "Sharpe, Arlene H"

  1. 1

    The diverse functions of the PD1 inhibitory pathway von Sharpe, Arlene H, Pauken, Kristen E

    ISSN: 1474-1733, 1474-1741, 1474-1741
    Veröffentlicht: England Nature Publishing Group 01.03.2018
    Veröffentlicht in Nature reviews. Immunology (01.03.2018)
    “… T cell activation is a highly regulated process involving peptide-MHC engagement of the T cell receptor and positive costimulatory signals. Upon activation, …”
    Volltext
    Journal Article
  2. 2

    ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity von Maazi, Hadi, Patel, Nisheel, Sankaranarayanan, Ishwarya, Suzuki, Yuzo, Rigas, Diamanda, Soroosh, Pejman, Freeman, Gordon J, Sharpe, Arlene H, Akbari, Omid

    ISSN: 1097-4180, 1097-4180
    Veröffentlicht: United States 17.03.2015
    Veröffentlicht in Immunity (Cambridge, Mass.) (17.03.2015)
    “… Allergic asthma is caused by Th2-cell-type cytokines in response to allergen exposure. Type 2 innate lymphoid cells (ILC2s) are a newly identified subset of …”
    Weitere Angaben
    Journal Article
  3. 3

    Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family von Schildberg, Frank A, Klein, Sarah R, Freeman, Gordon J, Sharpe, Arlene H

    ISSN: 1097-4180
    Veröffentlicht: United States 17.05.2016
    Veröffentlicht in Immunity (Cambridge, Mass.) (17.05.2016)
    “… Immune responses need to be controlled for optimal protective immunity and tolerance. Coinhibitory pathways in the B7-CD28 family provide critical inhibitory …”
    Weitere Angaben
    Journal Article
  4. 4

    Coinhibitory Pathways in Immunotherapy for Cancer von Baumeister, Susanne H, Freeman, Gordon J, Dranoff, Glenn, Sharpe, Arlene H

    ISSN: 1545-3278, 1545-3278
    Veröffentlicht: United States 20.05.2016
    Veröffentlicht in Annual review of immunology (20.05.2016)
    “… The immune system is capable of recognizing tumors and eliminates many early malignant cells. However, tumors evolve to evade immune attack, and the tumor …”
    Weitere Angaben
    Journal Article
  5. 5

    Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses von Joller, Nicole, Lozano, Ester, Burkett, Patrick R, Patel, Bonny, Xiao, Sheng, Zhu, Chen, Xia, Junrong, Tan, Tze G, Sefik, Esen, Yajnik, Vijay, Sharpe, Arlene H, Quintana, Francisco J, Mathis, Diane, Benoist, Christophe, Hafler, David A, Kuchroo, Vijay K

    ISSN: 1097-4180, 1097-4180
    Veröffentlicht: United States 17.04.2014
    Veröffentlicht in Immunity (Cambridge, Mass.) (17.04.2014)
    “… Foxp3(+) T regulatory (Treg) cells regulate immune responses and maintain self-tolerance. Recent work shows that Treg cells are comprised of many …”
    Weitere Angaben
    Journal Article
  6. 6

    Immune checkpoint inhibitor–associated myocarditis: manifestations and mechanisms von Moslehi, Javid, Lichtman, Andrew H., Sharpe, Arlene H., Galluzzi, Lorenzo, Kitsis, Richard N.

    ISSN: 0021-9738, 1558-8238, 1558-8238
    Veröffentlicht: United States American Society for Clinical Investigation 01.03.2021
    Veröffentlicht in The Journal of clinical investigation (01.03.2021)
    “… Immune checkpoint inhibitors (ICIs) have transformed the treatment of various cancers, including malignancies once considered untreatable. These agents, …”
    Volltext
    Journal Article
  7. 7

    Adverse Events Following Cancer Immunotherapy: Obstacles and Opportunities von Pauken, Kristen E., Dougan, Michael, Rose, Noel R., Lichtman, Andrew H., Sharpe, Arlene H.

    ISSN: 1471-4906, 1471-4981, 1471-4981
    Veröffentlicht: England Elsevier Ltd 01.06.2019
    Veröffentlicht in Trends in immunology (01.06.2019)
    “… Oncology has recently undergone a revolutionary change with widespread adoption of immunotherapy for many cancers. Immunotherapy using monoclonal antibodies …”
    Volltext
    Journal Article
  8. 8

    The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells von Sage, Peter T, Paterson, Alison M, Lovitch, Scott B, Sharpe, Arlene H

    ISSN: 1097-4180, 1097-4180
    Veröffentlicht: United States 18.12.2014
    Veröffentlicht in Immunity (Cambridge, Mass.) (18.12.2014)
    “… The receptor CTLA-4 has been implicated in controlling B cell responses, but the mechanisms by which CTLA-4 regulates antibody production are not known. Here …”
    Weitere Angaben
    Journal Article
  9. 9

    PD-1 pathway in tolerance and autoimmunity von Francisco, Loise M, Sage, Peter T, Sharpe, Arlene H

    ISSN: 0105-2896, 1600-065X, 1600-065X
    Veröffentlicht: Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01.07.2010
    Veröffentlicht in Immunological reviews (01.07.2010)
    “… Regulatory T cells (Tregs) and the PD-1: PD-ligand (PD-L) pathway are both critical to terminating immune responses. Elimination of either can result in the …”
    Volltext
    Journal Article
  10. 10

    Emerging concepts in PD-1 checkpoint biology von Pauken, Kristen E., Torchia, James A., Chaudhri, Apoorvi, Sharpe, Arlene H., Freeman, Gordon J.

    ISSN: 1044-5323, 1096-3618, 1096-3618
    Veröffentlicht: England Elsevier Ltd 01.02.2021
    Veröffentlicht in Seminars in immunology (01.02.2021)
    “… •The PD-1 pathway plays multifaceted roles in regulating immune responses.•PD-1 can modulate effector and memory T cells, Treg cells, NK cells, and ILCs.•PD-1 …”
    Volltext
    Journal Article
  11. 11

    Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway von Evavold, Charles L, Hafner-Bratkovič, Iva, Devant, Pascal, D'Andrea, Jasmin M, Ngwa, Elsy M, Boršić, Elvira, Doench, John G, LaFleur, Martin W, Sharpe, Arlene H, Thiagarajah, Jay R, Kagan, Jonathan C

    ISSN: 1097-4172, 1097-4172
    Veröffentlicht: United States 19.08.2021
    Veröffentlicht in Cell (19.08.2021)
    “… The process of pyroptosis is mediated by inflammasomes and a downstream effector known as gasdermin D (GSDMD). Upon cleavage by inflammasome-associated …”
    Weitere Angaben
    Journal Article
  12. 12

    Roles of CD48 in regulating immunity and tolerance von McArdel, Shannon L., Terhorst, Cox, Sharpe, Arlene H.

    ISSN: 1521-6616, 1521-7035, 1521-7035
    Veröffentlicht: United States Elsevier Inc 01.03.2016
    Veröffentlicht in Clinical immunology (Orlando, Fla.) (01.03.2016)
    “… CD48, a member of the signaling lymphocyte activation molecule family, participates in adhesion and activation of immune cells. Although constitutively …”
    Volltext
    Journal Article
  13. 13

    Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance von Park, Joon Seok, Gazzaniga, Francesca S., Wu, Meng, Luthens, Amalia K., Gillis, Jacob, Zheng, Wen, LaFleur, Martin W., Johnson, Sarah B., Morad, Golnaz, Park, Elizabeth M., Zhou, Yifan, Watowich, Stephanie S., Wargo, Jennifer A., Freeman, Gordon J., Kasper, Dennis L., Sharpe, Arlene H.

    ISSN: 0028-0836, 1476-4687, 1476-4687
    Veröffentlicht: London Nature Publishing Group UK 11.05.2023
    Veröffentlicht in Nature (London) (11.05.2023)
    “… The gut microbiota is a crucial regulator of anti-tumour immunity during immune checkpoint inhibitor therapy. Several bacteria that promote an anti-tumour …”
    Volltext
    Journal Article
  14. 14

    Inhibitors of the PD-1 Pathway in Tumor Therapy von LaFleur, Martin W, Muroyama, Yuki, Drake, Charles G, Sharpe, Arlene H

    ISSN: 1550-6606, 1550-6606
    Veröffentlicht: United States 15.01.2018
    Veröffentlicht in The Journal of immunology (1950) (15.01.2018)
    “… The programmed death 1 (PD-1) pathway delivers inhibitory signals that function as a brake for immune responses. This pathway limits the initiation and …”
    Weitere Angaben
    Journal Article
  15. 15

    Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity von Ringel, Alison E, Drijvers, Jefte M, Baker, Gregory J, Catozzi, Alessia, García-Cañaveras, Juan C, Gassaway, Brandon M, Miller, Brian C, Juneja, Vikram R, Nguyen, Thao H, Joshi, Shakchhi, Yao, Cong-Hui, Yoon, Haejin, Sage, Peter T, LaFleur, Martin W, Trombley, Justin D, Jacobson, Connor A, Maliga, Zoltan, Gygi, Steven P, Sorger, Peter K, Rabinowitz, Joshua D, Sharpe, Arlene H, Haigis, Marcia C

    ISSN: 1097-4172, 1097-4172
    Veröffentlicht: United States 23.12.2020
    Veröffentlicht in Cell (23.12.2020)
    “… Obesity is a major cancer risk factor, but how differences in systemic metabolism change the tumor microenvironment (TME) and impact anti-tumor immunity is not …”
    Weitere Angaben
    Journal Article
  16. 16

    PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity von Helou, Doumet Georges, Shafiei-Jahani, Pedram, Lo, Richard, Howard, Emily, Hurrell, Benjamin P., Galle-Treger, Lauriane, Painter, Jacob D., Lewis, Gavin, Soroosh, Pejman, Sharpe, Arlene H., Akbari, Omid

    ISSN: 2041-1723, 2041-1723
    Veröffentlicht: London Nature Publishing Group UK 10.08.2020
    Veröffentlicht in Nature communications (10.08.2020)
    “… Allergic asthma is a leading chronic disease associated with airway hyperreactivity (AHR). Type-2 innate lymphoid cells (ILC2s) are a potent source of T-helper …”
    Volltext
    Journal Article
  17. 17

    CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease von Sakai, Shunsuke, Kauffman, Keith D., Sallin, Michelle A., Sharpe, Arlene H., Young, Howard A., Ganusov, Vitaly V., Barber, Daniel L.

    ISSN: 1553-7374, 1553-7366, 1553-7374
    Veröffentlicht: United States Public Library of Science 01.05.2016
    Veröffentlicht in PLoS pathogens (01.05.2016)
    “… IFN-γ-producing CD4 T cells are required for protection against Mycobacterium tuberculosis (Mtb) infection, but the extent to which IFN-γ contributes to …”
    Volltext
    Journal Article
  18. 18

    B-cell-specific checkpoint molecules that regulate anti-tumour immunity von Bod, Lloyd, Kye, Yoon-Chul, Shi, Jingwen, Torlai Triglia, Elena, Schnell, Alexandra, Fessler, Johannes, Ostrowski, Stephen M., Von-Franque, Max Y., Kuchroo, Juhi R., Barilla, Rocky M., Zaghouani, Sarah, Christian, Elena, Delorey, Toni Marie, Mohib, Kanishka, Xiao, Sheng, Slingerland, Nadine, Giuliano, Christopher J., Ashenberg, Orr, Li, Zhaorong, Rothstein, David M., Fisher, David E., Rozenblatt-Rosen, Orit, Sharpe, Arlene H., Quintana, Francisco J., Apetoh, Lionel, Regev, Aviv, Kuchroo, Vijay K.

    ISSN: 0028-0836, 1476-4687, 1476-4687
    Veröffentlicht: London Nature Publishing Group UK 13.07.2023
    Veröffentlicht in Nature (London) (13.07.2023)
    “… The role of B cells in anti-tumour immunity is still debated and, accordingly, immunotherapies have focused on targeting T and natural killer cells to inhibit …”
    Volltext
    Journal Article
  19. 19

    Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth von Kleffel, Sonja, Posch, Christian, Barthel, Steven R, Mueller, Hansgeorg, Schlapbach, Christoph, Guenova, Emmanuella, Elco, Christopher P, Lee, Nayoung, Juneja, Vikram R, Zhan, Qian, Lian, Christine G, Thomi, Rahel, Hoetzenecker, Wolfram, Cozzio, Antonio, Dummer, Reinhard, Mihm, Jr, Martin C, Flaherty, Keith T, Frank, Markus H, Murphy, George F, Sharpe, Arlene H, Kupper, Thomas S, Schatton, Tobias

    ISSN: 1097-4172, 1097-4172
    Veröffentlicht: United States 10.09.2015
    Veröffentlicht in Cell (10.09.2015)
    “… Therapeutic antibodies targeting programmed cell death 1 (PD-1) activate tumor-specific immunity and have shown remarkable efficacy in the treatment of …”
    Weitere Angaben
    Journal Article
  20. 20

    T Cell Activation Depends on Extracellular Alanine von Ron-Harel, Noga, Ghergurovich, Jonathan M., Notarangelo, Giulia, LaFleur, Martin W., Tsubosaka, Yoshiki, Sharpe, Arlene H., Rabinowitz, Joshua D., Haigis, Marcia C.

    ISSN: 2211-1247, 2211-1247
    Veröffentlicht: United States Elsevier Inc 17.09.2019
    Veröffentlicht in Cell reports (Cambridge) (17.09.2019)
    “… T cell stimulation is metabolically demanding. To exit quiescence, T cells rely on environmental nutrients, including glucose and the amino acids glutamine, …”
    Volltext
    Journal Article